![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C12N 5/07 | (2010.01) | ||
C12N 5/16 | (2006.01) | ||
C12P 21/08 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
G01N 33/68 | (2006.01) | ||
C07K 16/46 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 35/02 | (2006.01) | ||
A61P 37/04 | (2006.01) |
(11) | Number of the document | 3789038 |
(13) | Kind of document | T |
(96) | European patent application number | 20198499.4 |
Date of filing the European patent application | 2011-05-13 | |
(97) | Date of publication of the European application | 2021-03-10 |
(45) | Date of publication and mention of the grant of the patent | 2022-10-05 |
(46) | Date of publication of the claims translation | 2022-12-12 |
(30) | Number | Date | Country code |
39565210 P | 2010-05-14 | US |
(72) |
LIU, Jie , US
WEISSMAN, Irving L. , US
MAJETI, Ravindra , US
|
(73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Humanizuoti ir chimeriniai monokloniniai antikūnai prieš CD47 |
HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47 |
Payment date | Validity (years) | Amount | |
2025-05-05 | 15 | 289.00 EUR |
2026-05-13 |